NCT02817477View on ClinicalTrials.gov

Intranasal Ketamine for Acute Traumatic Pain

PHASE4CompletedINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions
Acute Pain
Interventions
DRUG

Ketamine Hydrochloride

Delivered intranasally using an atomizer

DRUG

Morphine

Delivered either as an IM injection or a slow IV bolus

Trial Locations (1)

Unknown

Tel Aviv Medical Center, Tel Aviv

All Listed Sponsors
lead

Tel Aviv Medical Center

OTHER

NCT02817477 - Intranasal Ketamine for Acute Traumatic Pain | Biotech Hunter | Biotech Hunter